Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R. Dubberke, M.D., M.S.P.H., of the Washington University School of Medicine, St. Louis, Missouri, presented data at the 21st Annual Scientific Meeting of The Society for Healthcare Epidemiology of America (SHEA) in Dallas, Texas. Data for this research were obtained from the 2008 Nationwide Inpatient Sample, 2009 Medicare Provider Analysis and Review file, Florida fiscal year 2006-2007 Medicaid claims and 2007-2008 Medicare 5% Standard Analytical Files.

For a complete list of abstracts, including demographics, please visit the Resources page on our website: www.optimerpharma.com

About Fidaxomicin

Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI). In two Phase 3 trials for the treatment of CDI, fidaxomicin was equally effective in clinical cure when compared to vancomycin, the only FDA approved product for CDI. Fidaxomicin also demonstrated statistically significant reduction in recurrences and an increase in global cure rate, defined as cure without recurrence. Importantly, fidaxomicin reduced the risk of recurrence by 47% compared to vancomycin. The New England Journal of Medicine has published results from the first Phase 3 trial in an article titled, “Fidaxomicin versus Vancomycin for Clostridium difficile Infection,” which appeared in the February 3, 2011 issue.

About Clostridium difficile Infection (CDI)

Clostridium difficile infection (CDI), commonly referred to as “C. difficile” or “c-diff”, has become a significant medical problem in hospitals, long-term care facilities, and in the community and is estimated to afflict more than 700,000 people each year in the U.S. It is a serious illness resulting from infection of the inner lining of the colon by C. difficile bacteria, which produce toxins that cause inflammation of the colon, severe diarrhea and, in the most serious cases, death. Patients typically develop CDI from the use of broad-spectrum antibiotics that disrupt normal gastrointestinal (gut) flora, thus allowing C. difficile bacteria to flourish and produce toxins.

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society. Optimer has two anti-infective product candidates in development, fidaxomicin and Pruvel™ (prulifloxacin). Fidaxomicin is a narrow spectrum antibiotic being developed for the treatment of Clostridium difficile infection (CDI).

************************************************************

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” said Helen R. Park, MS, Chief Executive Officer of Power3, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Alzheimer’s is one among the well known form of dementia, a standard term for loss of memory along with other cerebral abilities major enough to obstruct routine. Alzheimer’s disease diseases is liable for 50 to 70 percent of dementia cases.

Alzheimer’s is not an everyday part of growing older, although the most significant known risk factor is increasing age, and the most of people with Alzheimer’s are 65 and older. But Alzheimer’s is not merely a sickness associated with aging. As much as a few per cent of people with the actual illness possess early-onset Alzheimer’s (also referred to as younger-onset), which regularly appears when someone is within his or her 40s or 50s.

Alzheimer’s worsens after a while. Alzheimer’s is some sort of progressing ailment, in which symptoms slowly progress over a period of time. In its early stages, forgetfulness is slight, however with late-stage Alzheimer’s disease, people today will not be able to carry on a conversation as well as react to their natural environment. Alzheimer’s disease is considered the 6th leading source of dying within the united states. Those that have Alzheimer’s disease live life typically 8 years after their signs or symptoms come to be obvious to many others, but yet survival can vary from three to 20 years, based on years of age along with other health conditions.

Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

************************************************************

S&W Seed Company (NASDAQ:SANW) announced that it has completed an agreement for a one-year, revolving line of credit with Wells Fargo Bank National Association with maximum availability of $5,000,000. The outstanding principal balance of the line of credit will bear interest at one month LIBOR plus 2%, which presently equals 2.25% per annum. The line of credit bears a standby fee on one-half percent (0.50%) per annum on the average daily unused amount of the line of credit, for a maximum of $25,000 if the line is not utilized.

Founded in 1980 and headquartered in the Central Valley of California, S&W Seed Company is a leading producer of warm climate, high yield alfalfa seed varieties, including varieties that can thrive in poor, saline soils, as verified over decades of university-sponsored trials. S&W also offers seed cleaning and processing at its 40-acre facility in Five Points, California.

************************************************************

S1 Corporation (Nasdaq:SONE), a leading global provider of payments and financial services software solutions, recently announced that UniCredit, a top 10 bank in Europe, has signed an agreement to use S1’s Corporate Banking and Trade Finance solutions. S1 will provide these online banking applications to the bank as a hosted service utilizing S1’s state-of-the-art data center.

Leading banks, credit unions, retailers, and processors need technology that adapts to the complex and challenging needs of their businesses. These organizations want solutions that can respond quickly to changes in the marketplace and help grow their businesses. For more than 20 years, S1 Corporation has been a leader in developing software products that offer flexibility and reliability.

************************************************************

Safe Bulkers, Inc. (NYSE:SB), an international provider of marine drybulk transportation services, announced today that it has filed its 2010 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission (the “SEC”). The 2010 Annual Report on Form 20-F is available by link through the Company’s website, www.safebulkers.com, under Investor Relations > SEC Filings.

Safe Bulkers, Inc. is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain and iron ore, along worldwide shipping routes for some of the world’s largest users of marine drybulk transportation services. The Company’s current fleet consists of 16 drybulk vessels, all built post-2003, and the Company has contracted to acquire nine additional drybulk newbuild vessels to be delivered at various times through 2013.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).

********************

AT&T, Inc. (NYSE:T) announced its AT&T Office@Hand app for iPhone, a mobile PBX application which allows small businesses with an existing wireless account from AT&T to configure and manage their office phone system on-the-go. The app, available now on the App Store, represents the latest example of AT&T’s commitment to help small businesses wirelessly enable their operations and expands the company’s portfolio of fixed mobile communication capabilities.

AT&T Inc. provides telecommunication products and services to consumers, businesses, and other telecommunication service providers under the AT&T brand worldwide. The company’s Wireless segment offers wireless voice communications services, including local wireless communications, long-distance, and roaming services with various postpaid and prepaid service plans.

********************

Spectra Energy Corp. (NYSE:SE) Chief Financial Officer, Pat Reddy, will speak at the Credit Suisse Energy Summit on Tuesday, February 8, 2011, in Vail, Colo. The presentation is scheduled to begin at approximately 11:10 a.m. MT (1:10 p.m. ET) and will be available via audio webcast. The presentation and webcast link can be accessed via the Investors Section of Spectra Energy’s Web site at www.spectraenergy.com. A replay of the webcast will be available for up to three months following the event.

Spectra Energy Corp, through its subsidiaries and equity affiliates, engages in the ownership and operation of a portfolio of complementary natural gas-related energy assets.

********************

Orofino Gold Corp. (ORFG.PK) has projects such as La Azul, San Carlos and Culo Alzado. La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vein systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz veins.

Gold is found in ores made up of rock with very small or microscopic particles of gold. This gold ore is often found together with quartz or sulfide minerals such as Fool’s Gold, which is a pyrite. These are called lode deposits. Native gold is also found in the form of free flakes, grains or larger nuggets that have been eroded from rocks and end up in alluvial deposits (called placer deposits). Such free gold is always richer at the surface of gold-bearing veins owing to the oxidation of accompanying minerals followed by weathering, and washing of the dust into streams and rivers, where it collects and can be welded by water action to form nuggets.

The Senderos de Oro Project is comprised of more than 3000 hectares of Gold and other mineral concessions in the minera mining area of central Sur de Bolivar. The Project resembles the La Bodega and Vetas California Projects, currently being explored and developed by Canadian Exploration Company Ventana Gold, for which EBX recently extended an unsolicited tender offer of $1.3 Billion.

La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vein systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz veins.

It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable “hidden porphyry” exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino “qualified person” as per the 43-101 rules.

Orofino will move ahead aggressively to pursue the current interpretations, work programs and drilling will begin soon.

Orofino Gold is a China based Gold and Silver Exploration Company founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

********************

Power3 Medical Products, Inc. (OTC.BB:PWRM), has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Alzheimer’s illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer’s type (PDDAT), or Alzheimer’s-is the most common sort of dementia. This unique incurable, degenerative, and deadly disorder was first explained German born professional as well as neuropathologist Alois Alzheimer in 1906 and was called after him. Most often, it really is determined in individuals over 65 years of age, although the less-prevalent early-onset Alzheimer’s can take place much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer’s is predicted to threaten 1 in 85 people today worldwide by the year 2050

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

For more information about this company please visit http://www.power3medical.com

********************

American Water Works Company, Inc. (NYSE:AWK) announced that it will host an Investor Conference on Tuesday, February 15 at the New York Stock Exchange. A live webcast of the conference will be accessible to the public from 8:00 a.m. to approximately 11:30 a.m. Eastern time, and posted on the investor relations section of the company’s website at www.amwater.com. The company will also issue a press release the morning of February 15 relaying preliminary fourth quarter and year-end 2010 results, as well as 2011 earnings guidance.

American Water Works Company, Inc. provides water and wastewater services to residential, commercial, and industrial customers in the United States and Canada. As of December 31, 2009, the company served approximately 16 million people with drinking water, wastewater, and other water-related services in 35 states and two Canadian provinces.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” said Helen R. Park, MS, Chief Executive Officer of Power3, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Parkinson’s disease (PD) are ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells. The 4 fundamental symptoms of PD are tremor, or moving in hands, arms, legs, jaw, and face; hardness, or perhaps tightness of your limbs and trunk; bradykinesia, or slowness to move; and postural lack of stability, or inable sense of balance and also co-ordination. As far as signs and symptoms, they are more noticable, patients might have trouble walking, talking, or finishing many other very simple tasks.

As symptoms get worse, individuals with Parkinson’s disease may have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking.

Power3 has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

~~~~~~~~~~~~~~~~

Rhino Resource Partners, L.P. (NYSE:RNO) announced that a cash distribution of $0.4208 per common unit and subordinated unit, which corresponds to the minimum quarterly distribution of $0.445 per unit, or $1.78 per unit on an annualized basis, prorated for the portion of the quarter after October 5, 2010, the closing date of Rhino’s initial public offering. This distribution will be paid on February 14, 2011 to all unitholders of record as of the close of business on February 1, 2011. Rhino is a growth-oriented limited partnership formed to control and operate steam and metallurgical coal properties and related assets in Central Appalachia, Northern Appalachia, the Illinois Basin and the Western Bituminous region.

Rhino Resource Partners LP produces and markets coal from its surface and underground mines located in Ohio, West Virginia, Kentucky, Colorado, and Utah. It sells coal primarily to electric utilities in the United States.

~~~~~~~~~~~~~~~~

National Health Partners, Inc. (OTCBB:NHPR), a leading provider of unique discount healthcare membership programs, is pleased to announce that the Company has achieved positive earnings for the quarter ended September 30, 2010 compared to a loss of $522,542 for the same period last year. Revenues for the 3rd quarter grew 12.3% over the same period last year. The Company attributes the net earnings to the significant cost-cutting initiatives taken over the past couple of quarters and which is continuing in the 4th quarter.

Today’s uninsured spend more for care-and are getting less-than those with insurance. However when the uninsured can’t pay, health care providers change those costs to the people who ultimately can pay-those who have insurance policies. That causes much higher monthly premiums for those who buy the insurance, male or female, on the market, as well as staff who get insurance to cover for themselves and their loved ones. The need for affordable healthcare alternatives has never been greater.

Based on a seemingly arbitrary matrix of things, it is a new perquisite or a fantasy having access to affordable medical in the United States. Government insurance applications are available for the elderly, the permanently disabled, people with failing kidneys, the particular impoverished and children from low-income individuals. But how poor should one be to be eligible varies from state to state and from year to year. Staff members at most large providers and many other people can take advantage of group insurance plans negotiated through their employers. However millions of people who operate in low-paying service, retail or perhaps contracting jobs need to seek individual plans, which may be unaffordable or perhaps unavailable because of their healthcare histories. Others obtain insurance with insurance deductibles so high or insurance policy coverage limits so very low that one bad accident or illness may possibly bankrupt them. The need for affordable healthcare alternatives has never been greater.

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage. The company is headquartered in Horsham, Pennsylvania.

To learn about NHPR visit: www.nationalhealthpartners.com

~~~~~~~~~~~~~~~~

Fair Isaac Corp. (NYSE:FICO) announced they are bringing the newest FICO® Score service to Canada. Based on the FICO® 8 Score, the new service offers a highly predictive general risk score designed specifically for the Canadian market. Validation tests are occurring now, and they indicate customers will receive three-to-five times the incremental improvement in risk prediction typically generated by an enhanced scoring model. The service will be available for full implementation in March 2011. Over the preceding two decades, FICO and TransUnion have partnered to deliver a unique combination of powerful analytics, agile service infrastructure and robust data to an extensive customer base in Canada, which includes leading national, regional and international lenders.

Fair Isaac Corporation, together with its subsidiaries, provides decision management solutions that enable businesses to automate, improve, and connect decisions to enhance business performance worldwide.

~~~~~~~~~~~~~~~~

CommonWealth REIT (NYSE:CWH) announced that it has scheduled its 2011 Annual Meeting of Shareholders for May 10, 2011. The record date for determination of shareholders entitled to vote at the meeting is February 18, 2011.

CommonWealth REIT is a real estate investment trust, or REIT, which primarily owns office and industrial properties throughout the United States, including approximately 17 million sq.ft. of leased industrial and commercial lands in Oahu, HI. CWH also owns a small and growing portfolio of office and industrial properties in Australia. CWH is headquartered in Newton, MA.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).  Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).